Skip to content

Reinterventions of Thoracic Endovascular Aortic Repair: a Retrospective Multicenter Cohort Study

Reinterventions of Thoracic Endovascular Aortic Repair: a Retrospective Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06438653
Enrollment
600
Registered
2024-06-03
Start date
2024-01-18
Completion date
2026-12-31
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Endovascular Aortic Repair

Keywords

Thoracic endovascular aortic repair, Reinterventions

Brief summary

We aimed to investigate the incidence of reinterventions in patients who underwent thoracic endovascular aortic repair (TEVAR) in multiple centers across Taiwan

Detailed description

This study analyzed the multicenter data set for TEVAR procedures performed between 2012 and 2017. Each patient's survival was verified with a query to the national data set. Student's t-test and χ2 analysis were used to compare continuous and categorical variables between the groups that required reintervention and those that did not, respectively. Kaplan-Meier methods were applied to analyze freedom from reintervention and survival rates.We aimed to investigate the incidence of reinterventions in patients who underwent thoracic endovascular aortic repair (TEVAR) in multiple centers across Taiwan

Interventions

OTHERNo-intervenyion

No-intervenyion

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who underwent thoracic endovascular aortic repair (TEVAR)

Exclusion criteria

* No thoracic endovascular aortic repair (TEVAR)

Design outcomes

Primary

MeasureTime frameDescription
Reintervention7 yearsThe incidence of reinterventions in patients who underwent thoracic endovascular aortic repair (TEVAR)

Secondary

MeasureTime frame
Mortality7 years

Countries

Taiwan

Contacts

PRINCIPAL_INVESTIGATORChih-Yang Chan, phd

National Taiwan University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026